Monday, August 22, 2016

BRIEF-Gilead Sciences - European Commission grants marketing authorization for Truvada

* European Commission grants marketing authorization for

Gilead's once-daily Truvada for reducing the risk of sexually

acquired HIV-1

Read more

No comments:

Post a Comment